Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
01/2013
01/01/2013US8343988 Inhibitors of histone deacetylase
01/01/2013US8343763 Heterocyclic derivatives as modulators of ion channels
12/2012
12/27/2012WO2012177653A2 Targeting the neuromuscular junction for treatment
12/27/2012WO2012175379A1 Homeopathic compositions for treating back, sciatic, or lumbar pain
12/27/2012US20120331575 Transgenic non-human animals
12/27/2012US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation
12/27/2012US20120329855 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
12/27/2012US20120329834 Compounds for the treatment of mitochondrial diseases
12/27/2012US20120329800 Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors
12/27/2012US20120329764 Methods and compositions for the treatment of migraine headaches
12/27/2012US20120329749 Methods Of Preventing Or Treating Disease States Related To Certain Metabolic Abnormalities
12/27/2012US20120329714 Prolactin Induced Increase in Neural Stem Cell Numbers
12/27/2012US20120328718 Pharmaceutical compositions
12/27/2012US20120328702 Nanoparticle compositions
12/27/2012US20120328701 Nanoparticle compositions, formulations thereof, and uses therefor
12/27/2012US20120328635 Chaperonin 10 variants
12/27/2012US20120328525 Nanoparticle compositions and components thereof
12/27/2012CA2839986A1 Targeting the neuromuscular junction for treatment
12/27/2012CA2839901A1 Homeopathic compositions for treating back, sciatic, or lumbar pain
12/26/2012EP2537831A1 Imidazole derivative
12/26/2012CN102839187A miR-29 absorption sequence, absorption carrier and uses thereof
12/26/2012CN102839101A Angelica dahurica health care liquor capable of promoting granulation and relieving pain
12/26/2012CN102838969A Ice slush and preparation method thereof
12/26/2012CN102838532A Novel compounds for a treatment of diseases associated with amyloid or amyloid-like proteins
12/26/2012CN102836438A Multi-component biological transport systems
12/26/2012CN102258492B Neostigmine bromide slow release preparation and its preparation method
12/26/2012CN102060941B 6-deoxy alpha-amino acid derivative cyclodextrin, preparation and application thereof
12/26/2012CN101942393B Huperzia serrata endophytic fungus shiraia sp. strain for producing huperzine A
12/26/2012CN100998864B Cyclosporin A semisolid skeleton capsule
12/25/2012US8337834 Methods of making enhanced, autologous fat grafts
12/25/2012US8337829 Conditioned medium and proliferated cell lines produced therefrom
12/20/2012WO2012173581A1 Thiocolchicoside, etodolac and famotidine combinations
12/20/2012WO2012173184A1 Lelia (liposome-based enzyme-linked immunoassay) technique using recombinant proteoliposomes
12/20/2012WO2012172012A1 New treatment for muscular dystrophies
12/20/2012WO2012171065A1 Treatment of allan-herndon-dudley syndrome with 3,5-diiodothyropropionic acid (ditpa).
12/20/2012US20120322861 Compositions and Methods for Treating Diseases
12/20/2012US20120322852 SMNdelta7 Degron: Novel Compositions and Methods of Use
12/20/2012US20120322778 Pharmaceutical compositions
12/20/2012US20120321668 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE
12/20/2012US20120321624 Targeting the neuromuscular junction for treatment
12/20/2012CA2841416A1 Method of selecting therapeutic indications
12/19/2012EP2535412A1 New treatment for muscular dystrophies
12/19/2012EP2535051A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
12/19/2012CN102834383A Cysteine protease inhibitors
12/19/2012CN102824553A Tincture for removing arthralgia and myalgia
12/19/2012CN102119970B Chinese medicinal composition for treating myasthenia gravis
12/19/2012CN101491329B Immunity adjustment function of corn extract and use thereof in food
12/18/2012US8334260 sFRP and peptide motifs that interact with sFRP and methods of their use
12/18/2012US8333958 HSA-free formulations of interferon-Beta
12/13/2012US20120316194 Apoptosis signal-regulating kinase 1 inhibitors
12/13/2012US20120316182 Compounds that modulate intracellular calcium
12/13/2012US20120316141 Method for providing neuroprotection from spinal muscular atrophy
12/13/2012US20120316114 Variants of C-type Natriuretic Peptide
12/13/2012US20120315285 Antibody Formulation
12/13/2012US20120315284 Composition for enhancing trail sensitivity comprising inhibitors for expression or activity of tip41 as a target gene of trail sensitizer
12/13/2012CA2838275A1 Methods for inhibiting muscle atrophy
12/12/2012EP2531604A2 Compositions and methods for enhanced parvovirus transduction
12/12/2012EP2531201A1 Synthesis of dgjnac from d-glucuronolactone and use to inhibit alpha-n-acetylgalactosaminidases
12/12/2012CN102822148A Therapeutic agent or prophylactic agent for fibromyalgia
12/11/2012US8329742 Macrocyclic compounds useful as pharmaceuticals
12/11/2012US8329662 Prodrug of an ICE inhibitor
12/11/2012US8329180 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
12/11/2012CA2483890C Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
12/11/2012CA2284459C Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
12/06/2012WO2012164234A1 Novel treatments
12/06/2012WO2012162778A1 Oral pharmaceutical composition and use thereof
12/06/2012WO2012138223A3 Compounds and methods for altering activin receptor-like kinase signalling
12/06/2012US20120309839 Dosing regimes for trans-clomiphene
12/06/2012US20120309825 Nitrate Esters And Their Use For The Treatment Of Muscle And Muscle Related Diseases
12/06/2012US20120309799 Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient
12/06/2012US20120309792 Tetrazole derivatives as nicotinic acetylcholine receptor modulators
12/06/2012US20120309721 Method for providing neuroprotection
12/06/2012US20120309716 Motor Function Improver
12/06/2012US20120309697 Methods of diagnosing and prognosing colonic polyps
12/06/2012US20120309684 Conjugates for delivery of biologically active compounds
12/06/2012US20120308644 Compositions for mucosal delivery of agents
12/06/2012US20120308588 Neprilysin inhibitors
12/06/2012US20120308518 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
12/06/2012US20120308493 Pawpaw and/or peach derived composition
12/05/2012EP2530156A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2530155A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2530154A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2530153A1 ENA nucleic acid drugs modifying splicing in mRNA precursor
12/05/2012EP2529734A1 Nitrate esters and their use for the treatment of muscle and muscle related diseases
12/05/2012CN102807617A Antibodies to M-CSF
12/05/2012CN102805841A Medicament for treating adverse reaction caused by anesthetics
12/05/2012CN102805804A Chinese medicinal composition for treating excessive heat type hiccup
12/05/2012CN102805795A Chinese medicinal composition for treating acute soft tissue injury of chest and hypochondrium and application thereof
12/05/2012CN102805785A Tai chi oil and preparation method thereof
12/05/2012CN101665489B Dehydrosilybin trialky ether and preparation method and medical application thereof
12/05/2012CN101565419B 7 and 20 dehydro-silybin dialky ether and preparation method and medicine use thereof
12/04/2012CA2573479C Effective use method of medicaments and method of preventing expression of side effect
12/04/2012CA2521177C Use of a botulinum neurotoxin to alleviate various disorders
12/04/2012CA2474798C Method and composition for treatment of inflammation and aids-associated neurological disorders
12/04/2012CA2463879C Glycoprotein compositions
12/04/2012CA2422294C Modulation of il-2- and il-15-mediated t cell responses
12/04/2012CA2246033C Therapeutic agent for herniated intervertebral disc
11/2012
11/29/2012WO2012161301A1 Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome
11/29/2012WO2012104823A3 Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases
11/29/2012US20120302645 Use of hydroxytyrosol for improving muscle differentiation
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 233